FR2926723B1 - ORAL PHARMACEUTICAL ASSOCIATIONS. - Google Patents

ORAL PHARMACEUTICAL ASSOCIATIONS.

Info

Publication number
FR2926723B1
FR2926723B1 FR0850460A FR0850460A FR2926723B1 FR 2926723 B1 FR2926723 B1 FR 2926723B1 FR 0850460 A FR0850460 A FR 0850460A FR 0850460 A FR0850460 A FR 0850460A FR 2926723 B1 FR2926723 B1 FR 2926723B1
Authority
FR
France
Prior art keywords
oral pharmaceutical
pharmaceutical associations
associations
oral
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0850460A
Other languages
French (fr)
Other versions
FR2926723A1 (en
Inventor
Anne Emmannuelle Lugrin
Jean Hoffelt
Claude Griscelli
Glaoui Guillaume El
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DUO GE
Original Assignee
DUO GE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0850460A priority Critical patent/FR2926723B1/en
Application filed by DUO GE filed Critical DUO GE
Priority to US12/864,397 priority patent/US20110027356A1/en
Priority to CA2713197A priority patent/CA2713197C/en
Priority to MX2010008071A priority patent/MX344778B/en
Priority to PCT/EP2009/050858 priority patent/WO2009092819A1/en
Priority to JP2010543522A priority patent/JP2011510049A/en
Priority to BRPI0907414-7A priority patent/BRPI0907414A2/en
Priority to EP09704297.2A priority patent/EP2249815B1/en
Priority to ES09704297T priority patent/ES2817504T3/en
Priority to CN200980106576.3A priority patent/CN101969933B/en
Priority to RU2010135514/15A priority patent/RU2493832C2/en
Priority to AU2009207580A priority patent/AU2009207580B8/en
Publication of FR2926723A1 publication Critical patent/FR2926723A1/en
Application granted granted Critical
Publication of FR2926723B1 publication Critical patent/FR2926723B1/en
Priority to JP2014223306A priority patent/JP5986169B2/en
Priority to US14/678,464 priority patent/US20160000715A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
FR0850460A 2008-01-25 2008-01-25 ORAL PHARMACEUTICAL ASSOCIATIONS. Expired - Fee Related FR2926723B1 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR0850460A FR2926723B1 (en) 2008-01-25 2008-01-25 ORAL PHARMACEUTICAL ASSOCIATIONS.
RU2010135514/15A RU2493832C2 (en) 2008-01-25 2009-01-26 Combinations of per oral medications, connected by coating
MX2010008071A MX344778B (en) 2008-01-25 2009-01-26 Combination of oral medicaments bonded by a wrapping.
PCT/EP2009/050858 WO2009092819A1 (en) 2008-01-25 2009-01-26 Combination of oral medicaments bonded by a wrapping
JP2010543522A JP2011510049A (en) 2008-01-25 2009-01-26 Oral pharmaceutical combination bound by packaging material
BRPI0907414-7A BRPI0907414A2 (en) 2008-01-25 2009-01-26 oral dosage form containing at least two medicinal products
EP09704297.2A EP2249815B1 (en) 2008-01-25 2009-01-26 Combinations of oral medicaments bonded by a wrapping
ES09704297T ES2817504T3 (en) 2008-01-25 2009-01-26 Oral Drug Combinations Bound by an Envelope
US12/864,397 US20110027356A1 (en) 2008-01-25 2009-01-26 Combination of Oral Medicaments Bonded by a Wrapping
CA2713197A CA2713197C (en) 2008-01-25 2009-01-26 Combinations of oral medicaments bonded by a wrapping
AU2009207580A AU2009207580B8 (en) 2008-01-25 2009-01-26 Combination of oral medicaments bonded by a wrapping
CN200980106576.3A CN101969933B (en) 2008-01-25 2009-01-26 The combination of the oral drugs combined by coating
JP2014223306A JP5986169B2 (en) 2008-01-25 2014-10-31 Oral pharmaceutical combination bound by packaging material
US14/678,464 US20160000715A1 (en) 2008-01-25 2015-04-03 Combinations of Oral Medicaments Bonded by a Wrapping

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0850460A FR2926723B1 (en) 2008-01-25 2008-01-25 ORAL PHARMACEUTICAL ASSOCIATIONS.

Publications (2)

Publication Number Publication Date
FR2926723A1 FR2926723A1 (en) 2009-07-31
FR2926723B1 true FR2926723B1 (en) 2010-06-18

Family

ID=39708936

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0850460A Expired - Fee Related FR2926723B1 (en) 2008-01-25 2008-01-25 ORAL PHARMACEUTICAL ASSOCIATIONS.

Country Status (1)

Country Link
FR (1) FR2926723B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201103752A2 (en) * 2011-04-18 2012-11-21 Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. Combinations of thiocolchicoside, diclofenac and lansoprazole.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH552510A (en) * 1972-02-14 1974-08-15 Aspro Nicholas Ltd Compressed tablets of special shape - to facilitate packing
CH624846A5 (en) * 1975-12-15 1981-08-31 Hoffmann La Roche Solid pharmaceutical unit dose form and process and apparatus for producing it
FR2524311A1 (en) * 1982-04-05 1983-10-07 Azalbert Gilles Multi:effect medical capsule with compartments contg. different medica - which are ingested simultaneously for programmed release to treat patient
DE4446468A1 (en) * 1994-12-23 1996-06-27 Basf Ag Process for the production of coated tablets
SE9500422D0 (en) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9600070D0 (en) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
AR024966A1 (en) * 1999-07-30 2002-10-30 Smithkline Beecham Plc PHARMACEUTICAL FORMULATION
US6254888B1 (en) * 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
US7125561B2 (en) * 2001-05-22 2006-10-24 Euro-Celtique S.A. Compartmentalized dosage form
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device

Also Published As

Publication number Publication date
FR2926723A1 (en) 2009-07-31

Similar Documents

Publication Publication Date Title
CY2018030I2 (en) PHARMACEUTICAL FORM 514
LTC2140867I2 (en) Pharmaceutical composition
BRPI1010768A2 (en) compound and pharmaceutical composition.
BRPI0906962A2 (en) Compound and pharmaceutical composition
BRPI0906556A2 (en) Compound and pharmaceutical composition
BRPI0822722A2 (en) Implement for oral care.
BRPI0918652A2 (en) Pharmaceutical compositions and related release methods.
BRPI0920521A2 (en) pharmaceutical combination
BRPI0906802A2 (en) Implement for oral care.
BRPI0820381A2 (en) Pharmaceutical Formulations
DK2131813T3 (en) Topical pharmaceutical formulations
BRPI0910503A2 (en) compounds, pharmaceutical compositions and their uses.
BRPI0721651A2 (en) PHARMACEUTICAL COMPOSITION
BRPI0812354A2 (en) NON-Aqueous PHARMACEUTICAL COMPOSITION.
BRPI0719398A2 (en) Pharmaceutical composition.
BRPI0917681A2 (en) Compound and pharmaceutical composition
DK2254873T3 (en) Benzodiazepine Compound and Pharmaceutical Composition.
BRPI1016190A2 (en) pharmaceutical compounds.
BRPI0807078A2 (en) COMPOUND AND PHARMACEUTICAL FORMULATION
DK2285413T3 (en) Pharmaceutical composition
BRPI0921654A2 (en) pharmaceutical formulation
BR112012000831A2 (en) related compounds, pharmaceutical compositions and methods
BRPI0921313A2 (en) pharmaceutical composition
BRPI0914182A2 (en) compound and pharmaceutical composition
BRPI0922286A2 (en) quinolone compound and pharmaceutical composition.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20170929

RN Application for restoration

Effective date: 20171030

PLFP Fee payment

Year of fee payment: 11

FC Decision of inpi director general to approve request for restoration

Effective date: 20180116

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16